English

More about this topic

Business

New tariffs from the US are about to hit the pharmaceutical sector

Despite sparking global-market turmoil with last week’s announcement, the US President is promising new tariffs, now targeting the previously exempted pharmaceutical sector.

Health news

Pharma companies ask EU Commission to negotiate with US over tariffs

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs and other medical products.

Europe News

Did pharma sector dodge Trump’s tariffs? The EU's not so sure

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Markets

Novo Nordisk shares post the biggest monthly decline since 2002

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, forecasting a potential price upside of up to 60% over the next 12 months.

ADVERTISEMENT

Health news

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Europe News

Commission to push 'buy European' in new critical medicines act

The European Commission has proposed new rules aimed at strengthening the security of supply and availability of critical medicines, prioritising EU-based suppliers in public procurement.

Healthcare

Which critical medicines are in short supply in the EU?

The drug shortages are the result of manufacturing problems, increased demand, and other issues.

Markets

Novo Nordisk shares jump after Wegovy price cuts announced

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its weight-loss treatment Wegovy.

Health news

Commission playing catch up with US, China in life science sector

Gene therapies, multi-country clinical trials, and AI-driven personalised medicine are some of the priorities the EU executive is working on for the upcoming Life science strategy, according to details shared with member states.

Economy

Here’s why Trump’s tariffs could hit Ireland’s pharma sector hardest

The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared to other EU economies.

Health news

EU’s medicine stockpiling challenged by national security concerns

The European Union’s efforts to build a medical stockpile and strengthen health crisis preparedness face a major challenge: a blind spot over national reserves. Many member states are reluctant to share information due to security concerns.

Business

AstraZeneca reports strong results boosted by promising trials

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products.

Health news

GLP-1 drug akin to Ozempic showed no benefits for Parkinson’s disease

GLP-1 drugs are being explored as potential treatments for a range of conditions.

Health news

Commission cuts feedback amid races to push Critical Medicines Act

The EU executive is expected to push ahead with an extremely streamlined timeline for a key piece of health legislation, aiming to present it within the first 100 days of the new administration.

Healthcare

UK pharmacies urge tougher rules for online sales of weight loss drugs

The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand.

Healthcare

Europe launches medicine shortage monitoring in 2025

Among the health policy novelties of 2025, a new tool developed by the European Medicines Agency (EMA) is set to harmonise monitoring of medicine shortages across Europe.

Health news

Race against time for EU’s Critical Medicines Act

Wanted in the first 100 days of the new legislative mandate, doubts linger over whether the European Commission will unveil the Critical Medicines Act on time.

Healthcare

Are new, expensive drugs worth it? Not if you're not a recipient

A new study has found that the approval of new drugs in England has come at a heavy cost to the health of many others due to a loss of funding.

Economy

How could Europe's biggest economy lose out under Trump's plans?

The German economy, already in decline, could be about to lose 1% of GDP due to the trade tariffs, promised by US President-Elect Donald Trump.

Business

Bayer shares fall as pharma giant’s results fail to cheer investors

Bayer’s share price fell on Tuesday, following the company releasing lacklustre third quarter earnings with a warning that the current challenges may also impact next year’s results as well.